Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ioanna Gouni-Berthold

Showing results (1-10 of 136) with videos related to

Pageof 14
Sort By:
Med (New York, N.Y.)|June 14, 2025
siRNAs targeting ANGPTL3 for mixed dyslipidemiaIoanna Gouni-Berthold
Atherosclerosis. Supplements|May 5, 2015
PCSK9 antibodies: A new class of lipid-lowering drugsIoanna Gouni-Berthold
Med (New York, N.Y.)|November 15, 2025
Olezarsen in moderate hypertriglyceridemia: The Essence-TIMI 73b trialIoanna Gouni-Berthold
Journal of the Endocrine Society|February 22, 2020
Significant Quality of Life Improvement Observed in a Patient With FCS Associated With a Marked Reduction in TriglyceridesIoanna Gouni-Berthold
Atherosclerosis. Supplements|November 4, 2017
The role of antisense oligonucleotide therapy against apolipoprotein-CIII in hypertriglyceridemiaIoanna Gouni-Berthold
Atherosclerosis. Supplements|November 4, 2017
The efficacy of anti-PCSK9 antibodies: Results from recent trialsIoanna Gouni-Berthold
Deutsches Arzteblatt International|April 15, 2024
Special Aspects of Cholesterol Metabolism in WomenIoanna Gouni-Berthold, Ulrich Laufs
Medizinische Klinik (Munich, Germany : 1983)|June 29, 2006
Diabetic ketoacidosis and hyperosmolar hyperglycemic stateIoanna Gouni-Berthold, Wilhelm Krone
Current Medicinal Chemistry|June 10, 2017
APOC-III Antisense Oligonucleotides: A New Option for the Treatment of HypertriglyceridemiaJoel Schmitz, Ioanna Gouni-Berthold
Current Medicinal Chemistry|June 17, 2017
Role of Anti-PCSK9 Antibodies in the Treatment of Patients with Statin IntoleranceJulia Schreml, Ioanna Gouni-Berthold
Pageof 14

Showing results (1-10 of 136) with videos related to

Sort By:
Pageof 14
Med (New York, N.Y.)|June 14, 2025
siRNAs targeting ANGPTL3 for mixed dyslipidemiaIoanna Gouni-Berthold
Atherosclerosis. Supplements|May 5, 2015
PCSK9 antibodies: A new class of lipid-lowering drugsIoanna Gouni-Berthold
Med (New York, N.Y.)|November 15, 2025
Olezarsen in moderate hypertriglyceridemia: The Essence-TIMI 73b trialIoanna Gouni-Berthold
Journal of the Endocrine Society|February 22, 2020
Significant Quality of Life Improvement Observed in a Patient With FCS Associated With a Marked Reduction in TriglyceridesIoanna Gouni-Berthold
Atherosclerosis. Supplements|November 4, 2017
The role of antisense oligonucleotide therapy against apolipoprotein-CIII in hypertriglyceridemiaIoanna Gouni-Berthold
Atherosclerosis. Supplements|November 4, 2017
The efficacy of anti-PCSK9 antibodies: Results from recent trialsIoanna Gouni-Berthold
Deutsches Arzteblatt International|April 15, 2024
Special Aspects of Cholesterol Metabolism in WomenIoanna Gouni-Berthold, Ulrich Laufs
Medizinische Klinik (Munich, Germany : 1983)|June 29, 2006
Diabetic ketoacidosis and hyperosmolar hyperglycemic stateIoanna Gouni-Berthold, Wilhelm Krone
Current Medicinal Chemistry|June 10, 2017
APOC-III Antisense Oligonucleotides: A New Option for the Treatment of HypertriglyceridemiaJoel Schmitz, Ioanna Gouni-Berthold
Current Medicinal Chemistry|June 17, 2017
Role of Anti-PCSK9 Antibodies in the Treatment of Patients with Statin IntoleranceJulia Schreml, Ioanna Gouni-Berthold
Pageof 14